Fate Therapeutics (FATE) FCF Margin Growth (1y) (2016 - 2026)
Fate Therapeutics (FATE) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fate Therapeutics | 302.48 Mn | 302.48 Mn | - | -27,549.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27,549.00 |
| Dec 31, 2025 | -60,753.00 |
| Sep 30, 2025 | -41,273.00 |
| Jun 30, 2025 | -82,816.00 |
| Mar 31, 2025 | -38,246.00 |
| Dec 31, 2024 | 104,184.00 |
| Sep 30, 2024 | 74,619.00 |
| Jun 30, 2024 | 281,073.00 |
| Mar 31, 2024 | -167,882.00 |
| Dec 31, 2023 | -243,587.00 |
| Sep 30, 2023 | -127,392.00 |
| Jun 30, 2023 | -291,225.00 |
| Mar 31, 2023 | 31,486.00 |
| Dec 31, 2022 | 58,044.00 |
| Sep 30, 2022 | -28,900.00 |
| Jun 30, 2022 | -2,631.00 |
| Mar 31, 2022 | -10,249.00 |
| Dec 31, 2021 | -54,336.00 |
| Sep 30, 2021 | 30,319.00 |
| Jun 30, 2021 | -107,820.00 |